Coltene outperforms market in full-year 2012

Coltene has expressed satisfaction with its financial performance in 2012, during which it achieved a net sales total of 158.1 million Swiss francs (110.41 million pounds).

The dental technology firm's turnover rose by 8.2 percent year over year during this period, while income, earnings and profit levels saw double-digit increases that outperformed the market as a whole.

According to the company's financial report, these positive developments "are primarily attributable to the higher sales level, operational advances and unified internal processes by sharing group?wide expertise and production knowhow".

Coltene was able to consolidate its product portfolio and review its internal organisation and processes during the last 12 months, while also creating a fresh business strategy under new chief executive officer Martin Schaufelberger.

As a result, the firm is now aiming to continue increasing its sales levels above the market average in 2013.

Based in Switzerland, Coltene is a global leader in dental consumables and small equipment, operating its main production sites in Switzerland, the US, Germany and Hungary.